Zila News
Most Popular Zila Story
C&L: Bethune tapped as interim Zila CEO
Zila Chairman David Bethune is taking on the role of acting CEO. That post has been empty since last June, when Doug Burkett left the job. Barr Pharmaceuticals announced the following promotions:... Read more...
Latest Headlines
- April 2, 2008
- August 15, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
